Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $2.39 Million - $2.68 Million
41,361 Added 8.9%
506,054 $29.4 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $6.68 Million - $7.42 Million
104,879 Added 29.15%
464,693 $29.7 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $333,872 - $378,686
-5,081 Reduced 1.39%
359,814 $24.9 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $2.77 Million - $3.28 Million
-40,447 Reduced 9.98%
364,895 $26.3 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $247 - $146,226
1,903 Added 0.47%
405,342 $28.8 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $8.17 Million - $9 Million
-112,507 Reduced 21.81%
403,439 $31.1 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $4.63 Million - $5.56 Million
-75,386 Reduced 12.75%
515,946 $37.7 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $6.33 Million - $7.38 Million
118,081 Added 24.95%
591,332 $36.9 Million
Q3 2021

Nov 17, 2021

SELL
$59.17 - $69.31 $501,465 - $587,402
-8,475 Reduced 1.76%
473,251 $28 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $732,209 - $797,376
11,827 Added 2.52%
481,726 $32.2 Million
Q1 2021

May 18, 2021

BUY
$59.34 - $66.74 $5.12 Million - $5.75 Million
86,204 Added 22.47%
469,899 $29.7 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $3.16 Million - $3.58 Million
54,657 Added 16.61%
383,695 $23.8 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $3.7 Million - $4.1 Million
64,453 Added 24.36%
329,038 $19.8 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $2.91 Million - $3.41 Million
-53,168 Reduced 16.73%
264,585 $15.6 Million
Q1 2020

Apr 13, 2020

SELL
$46.4 - $67.43 $2.9 Million - $4.22 Million
-62,545 Reduced 16.45%
317,753 $17.7 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $7.11 Million - $9.28 Million
-144,544 Reduced 27.54%
380,298 $24.4 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $2.04 Million - $2.42 Million
47,721 Added 10.0%
524,842 $26.6 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $2.53 Million - $2.8 Million
56,756 Added 13.5%
477,121 $21.6 Million
Q1 2019

Apr 18, 2019

BUY
$45.12 - $53.8 $19 Million - $22.6 Million
420,365 New
420,365 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Deprince Race & Zollo Inc Portfolio

Follow Deprince Race & Zollo Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.